These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3343594)

  • 1. Chronic treatment with choline or scopolamine indicates the presence of muscarinic cholinergic receptor plasticity in the frontal cortex of young but not of aged mice.
    Pilch H; Müller WE
    J Neural Transm; 1988; 71(1):39-43. PubMed ID: 3343594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piracetam elevates muscarinic cholinergic receptor density in the frontal cortex of aged but not of young mice.
    Pilch H; Müller WE
    Psychopharmacology (Berl); 1988; 94(1):74-8. PubMed ID: 3126530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scopolamine reduces frontal cortex perfusion.
    Honer WG; Prohovnik I; Smith G; Lucas LR
    J Cereb Blood Flow Metab; 1988 Oct; 8(5):635-41. PubMed ID: 3417793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aged dogs demonstrate both increased sensitivity to scopolamine impairment and decreased muscarinic receptor density.
    Araujo JA; Nobrega JN; Raymond R; Milgram NW
    Pharmacol Biochem Behav; 2011 Apr; 98(2):203-9. PubMed ID: 21238475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasticity of brain muscarinic receptors in aging rats: the adaptative response to scopolamine and ethanol treatment.
    Pietrzak ER; Wilce PA; Shanley BC
    Neurosci Lett; 1989 Oct; 104(3):331-5. PubMed ID: 2812547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies.
    Flynn DD; Weinstein DA; Mash DC
    Ann Neurol; 1991 Mar; 29(3):256-62. PubMed ID: 2042942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic drug effects and brain muscarinic receptor binding in aged rats.
    Pedigo NW; Minor LD; Krumrei TN
    Neurobiol Aging; 1984; 5(3):227-33. PubMed ID: 6514108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of long-term dietary choline and phosphatidylcholine administration on muscarinic receptors in aged mouse brain.
    Muma NA; Rowell PP; Schultz GS
    Neurol Res; 1988 Sep; 10(3):130-5. PubMed ID: 2905774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortico-hippocampal APP and NGF levels are dynamically altered by cholinergic muscarinic antagonist or M1 agonist treatment in normal mice.
    Seo H; Ferree AW; Isacson O
    Eur J Neurosci; 2002 Feb; 15(3):498-506. PubMed ID: 11876777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic scopolamine treatment and brain cholinergic function.
    Marks MJ; O'Connor MF; Artman LD; Burch JB; Collins AC
    Pharmacol Biochem Behav; 1984 May; 20(5):771-7. PubMed ID: 6739517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human serial learning: enhancement with arecholine and choline impairment with scopolamine.
    Sitaram N; Weingartner H; Gillin JC
    Science; 1978 Jul; 201(4352):274-6. PubMed ID: 351808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease.
    Reinikainen KJ; Riekkinen PJ; Halonen T; Laakso M
    Life Sci; 1987 Jul; 41(4):453-61. PubMed ID: 3600187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choline inhibits acetylcholine release via presynaptic muscarine receptors.
    Kilbinger H; Kruel R
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Apr; 316(2):131-4. PubMed ID: 7242699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging.
    DeKosky ST; Scheff SW; Markesbery WR
    Neurology; 1985 Oct; 35(10):1425-31. PubMed ID: 4033925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic cholinergic receptors in the hippocampus of aged rats: influence of choline alphoscerate treatment.
    Amenta F; Liu A; Zeng YC; Zaccheo D
    Mech Ageing Dev; 1994 Oct; 76(1):49-64. PubMed ID: 7845062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scopolamine and Medial Frontal Stimulus-Processing during Interval Timing.
    Zhang Q; Jung D; Larson T; Kim Y; Narayanan NS
    Neuroscience; 2019 Aug; 414():219-227. PubMed ID: 31299344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic receptor plasticity in rats lesioned in the nucleus basalis of Meynert.
    Vige X; Briley M
    Neuropharmacology; 1989 Jul; 28(7):727-32. PubMed ID: 2761681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of muscarinic acetylcholine receptor subtypes in diffuse lewy body disease: relation to Alzheimer's disease.
    Shiozaki K; Iseki E; Uchiyama H; Watanabe Y; Haga T; Kameyama K; Ikeda T; Yamamoto T; Kosaka K
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):209-13. PubMed ID: 10406992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physostigmine reversal of scopolamine-induced hypofrontality.
    Prohovnik I; Arnold SE; Smith G; Lucas LR
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):220-8. PubMed ID: 9040502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scopolamine induces an increase in muscarinic receptor level in rat hippocampus.
    Ben-Barak J; Dudai Y
    Brain Res; 1980 Jul; 193(1):309-13. PubMed ID: 7378826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.